ArticleBone research2026
Mineralized DNA tetrahedron-structured hydrogels: a dual-functional Scaffold for immunomodulation and bone regeneration.
Article in Bone research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Engineering high-fidelity bone organoids: Operational classification, multilineage crosstalk, biofabrication evidence, and translational validation.Materials today. Bio · 2026Article
- Tetrahedral Framework Nucleic Acid Delivery of miR-210-3p Promotes Femoral Bone Regeneration Through EFNA3/AKT/STAT3-Mediated Immunomodulation.Cell proliferation · 2026Article
- Bioengineering DNA-based hydrogels for regenerative medicine: A review of programmable design, chemical synthesis and therapeutic potential.Materials today. Bio · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Clinical limitations of autografts and allografts have driven advances in bone tissue engineering. Emerging biomaterials offer tunable mechanical and bio-regenerative properties for bone reconstruction. DNA hydrogels have attracted increasing attention due to their extracellular matrix-like architecture and excellent cargo-loading capacity. However, their rapid degradation and limited immunomodulatory activity have hindered their long-term efficacy in bone regeneration. To address these limitations, a mineralized tetrahedral framework nucleic acids (tFNAs) hydrogel (Cap-gel) was engineered to integrate early immunoregulation with sustained osteogenic activity. The stable and programmable spatial structure of tFNAs not only promotes macrophage polarization toward the M2 phenotype by presenting immunomodulatory ligands but also serves as a nucleation template for calcium phosphate crystallization, leading to the formation of nano-mineralized structures with controlled morphology. In vitro, Cap-gel promoted osteogenic differentiation via both immune-dependent and independent pathways, while in vivo, it modulated early immune responses and accelerated bone regeneration in a calvarial defect model. In summary, this study introduces a novel tFNA-based mineralized DNA hydrogel system that integrates immunomodulation and osteogenesis, providing a promising strategy for enhanced bone repair in tissue engineering applications. A mineralized DNA hydrogel is constructed by sticky-end self-assembly of tetrahedral framework nucleic acids followed by calcium-phosphate deposition. The hydrogel exhibits antioxidant, immunomodulatory, and osteoinductive properties, enabling sequential regulation of the bone healing microenvironment and effectively promoting cranial defect regeneration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.